Paul E. Firuta

Paul E. Firuta discloses dealings in 2 companies, chiefly uniQure N.V. and NPS Pharmaceuticals Inc. We count 4 filings; the first trade dates from 21 February 2015 and the latest from 26 January 2018.

Every open-market trade on record is a sale: 1 sale worth €98k. Other entries cover 2 share grants. Since January 2018: no purchases and 1 sale on the market.

The newest entry dates from 30 January 2018: a share grant, in uniQure N.V. The median gap between a trade and its publication by SEC (Form 4) is 3 days. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.